AKT1 and Insulin resistance: NF-κB inhibits the activation of phosphatidylinositol 3-kinase- (PI3K-) protein kinase B (AKT) signaling pathway by inhibiting phosphorylation of insulin receptor substrate (IRS), resulting in insulin resistance [9].